İ. GÜL Et Al. , "Prognostic role of soluble suppression of tumorigenicity-2 on cardiovascular mortality in outpatients with heart failure," ANATOLIAN JOURNAL OF CARDIOLOGY , vol.18, no.3, pp.200-205, 2017
GÜL, İ. Et Al. 2017. Prognostic role of soluble suppression of tumorigenicity-2 on cardiovascular mortality in outpatients with heart failure. ANATOLIAN JOURNAL OF CARDIOLOGY , vol.18, no.3 , 200-205.
GÜL, İ., Yucel, O., ZARARSIZ, A., DEMİRPENÇE, Ö., YÜCEL, H., ZORLU, A., ... YILMAZ, M. B.(2017). Prognostic role of soluble suppression of tumorigenicity-2 on cardiovascular mortality in outpatients with heart failure. ANATOLIAN JOURNAL OF CARDIOLOGY , vol.18, no.3, 200-205.
GÜL, İBRAHİM Et Al. "Prognostic role of soluble suppression of tumorigenicity-2 on cardiovascular mortality in outpatients with heart failure," ANATOLIAN JOURNAL OF CARDIOLOGY , vol.18, no.3, 200-205, 2017
GÜL, İBRAHİM Et Al. "Prognostic role of soluble suppression of tumorigenicity-2 on cardiovascular mortality in outpatients with heart failure." ANATOLIAN JOURNAL OF CARDIOLOGY , vol.18, no.3, pp.200-205, 2017
GÜL, İ. Et Al. (2017) . "Prognostic role of soluble suppression of tumorigenicity-2 on cardiovascular mortality in outpatients with heart failure." ANATOLIAN JOURNAL OF CARDIOLOGY , vol.18, no.3, pp.200-205.
@article{article, author={İBRAHİM GÜL Et Al. }, title={Prognostic role of soluble suppression of tumorigenicity-2 on cardiovascular mortality in outpatients with heart failure}, journal={ANATOLIAN JOURNAL OF CARDIOLOGY}, year=2017, pages={200-205} }